Poster (Scientific congresses and symposiums)
Block of SK channels by the sigma agonist 1,3-di-o-tolyl-guanidine: evidence for a novel site of action for SK blockers
Dilly, Sébastien; Lamy, Cédric; Snyders, Dirk et al.
2010Belgian Society for Fundamental and Clinical Physiology and Pharmacology, Autumn Meeting 2010
 

Files


Full Text
Abstract_BSFCPP2010.pdf
Publisher postprint (43.44 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] Among ion channels involved in the control of neuronal activity, small conductance calcium-activated potassium channels (SK) represent an interesting therapeutic target. Indeed, they underlie medium duration afterhyperpolarizations (mAHPs) in many types of neurons, thus inhibiting cell excitability. Three subtypes of SK subunits, SK1, SK2 and SK3, have been cloned and are expressed differentially within the central nervous system (CNS). Blocking SK channels might be beneficial in the treatment of several CNS disorders such as depression (SK3), Parkinson’s disease (SK3) and cognitive disorders (SK2). So far, the prototypical blocker of SK channels is apamin, an octadecapeptide from bee venom. We have recently shown that apamin blocks SK channels by binding to a site distinct from that used by classical pore blockers such as tetraethylammonium (TEA) (Lamy et al. J. Biol. Chem. 2010, 285, 27067-77). We have also demonstrated that the nonpeptide blocker N-methyl-laudanosine (NML) (Scuvée-Moreau et al. J. Pharmacol. Exp. Ther. 2002, 302, 1176-83) competes for the binding site of the toxin. Further, our research team has recently shown that the sigma agonist 1,3-di-o-tolyl-guanidine (DTG) directly blocks SK currents in a voltage-independent manner (Lamy et al. Eur. J. Pharmacol. 2010, 641, 23-8). We have combined patch clamp experiments on cell lines with molecular modelling and mutagenesis, to try to identify the site where DTG blocks. DTG was found to be equipotent on wild-type (WT) and apamin-insensitive (e.g. SK2H337N) channels. Moreover, mutated channels with increased sensitivity to TEA (SK3V520F: mean IC50 of TEA: 0.34 mM versus 11 mM for WT channels) were blocked by DTG with the same potency as WT channels. Thus, DTG does not seem to share the site of either apamin or TEA. Modelling data were in agreement with this possibility because of the identification of various potential binding sites. Although preliminary, these results suggest the existence of yet another binding site in the outer pore region of SK channels.
Research center :
Département de pharmacie, Laboratoire de chimie pharmaceutique
GIGA-Neurosciences, Laboratoire de pharmacologie
Disciplines :
Pharmacy, pharmacology & toxicology
Computer science
Author, co-author :
Dilly, Sébastien ;  Université de Liège - ULiège > Département de Pharmacie / Giga-Neurosciences > Chimie pharmaceutique / Pharmacologie
Lamy, Cédric;  Université de Liège - ULiège > Giga-Neurosciences > Pharmacologie
Snyders, Dirk;  University of Antwerp > Department of Biomedical Sciences > Laboratory for Molecular Biophysics, Physiology and Pharmacology
Liégeois, Jean-François ;  Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Seutin, Vincent ;  Université de Liège - ULiège > Giga-Neurosciences > Pharmacologie
Language :
English
Title :
Block of SK channels by the sigma agonist 1,3-di-o-tolyl-guanidine: evidence for a novel site of action for SK blockers
Publication date :
16 October 2010
Event name :
Belgian Society for Fundamental and Clinical Physiology and Pharmacology, Autumn Meeting 2010
Event organizer :
Belgian Society for Fundamental and Clinical Physiology and Pharmacology
Event place :
Brussels, Belgium
Event date :
16 octobre 2010
Funders :
F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE]
the Belgian Science Policy
ULiège - Université de Liège [BE]
Available on ORBi :
since 09 February 2011

Statistics


Number of views
74 (15 by ULiège)
Number of downloads
2 (2 by ULiège)

Bibliography


Similar publications



Contact ORBi